Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 17, 2026
TickeronGET DAILY SIGNALS
Why Is SurgePays (SURG) Stock Up +31.06% Today?

Why Is SurgePays (SURG) Stock Up +31.06% Today?

Key Takeaways

  • SURG shares climbed roughly 31% intraday after a strategic announcement.
  • The primary catalyst was a non-binding letter of intent to form a smartphone rent-to-own joint venture with LowWeeklyPayments (LWP).
  • SurgePays would hold a 51% controlling stake as Managing Member, with more than 100 dealers already onboarded and a target of 500 locations by year-end.
  • The move builds on a recent $27.5 million asset sale that strengthened the balance sheet and Nasdaq equity compliance.
  • As a low-priced micro-cap trading near its 52-week low, percentage swings are amplified even on modest volume.
  • Traders are watching for a definitive operating agreement and further dealer and customer-adoption metrics.

Opening Summary

SurgePays, Inc. (SURG), a Bartlett, Tennessee-based wireless and fintech company serving subprime and underserved consumers, saw its shares rally sharply on Wednesday. The stock advanced approximately 31.06%, climbing from a prior close of $0.1439 to around $0.1886 in midday trading. The move followed the company's announcement that it had signed a non-binding letter of intent with All Prepaid, LLC, doing business as LowWeeklyPayments, to scale a smartphone rent-to-own program across its independent retail dealer network.

Smartphone Rent-to-Own Joint Venture Drives the Rally

The principal catalyst was a corporate announcement rather than an earnings report or analyst action. SurgePays disclosed a letter of intent to form a joint venture with LowWeeklyPayments to expand a rent-to-own smartphone offering aimed at consumers who are frequently turned away by traditional financing programs. Under the proposed structure, SurgePays would hold a 51% interest and act as Managing Member, while LWP would hold the remaining 49%.

The venture would operate through LWP-SURGE, LLC, a Wyoming entity formed on September 2, 2026, combining SurgePays' retail distribution, dealer recruiting, and corporate infrastructure with LWP's proprietary rent-to-own platform, approval matrix, and in-store payment technology. Management said the program has already helped onboard more than 100 dealers, describing it as one of the strongest store-acquisition results the company has seen, with a target of 500 locations by the end of the year. The model allows customers to take home a smartphone under a low weekly payment plan and own the device outright once payments are complete, regardless of credit history or bank account.

Balance Sheet Repositioning Provides a Supportive Backdrop

The rally also reflects improving sentiment following a recent portfolio simplification. Earlier in the month, SurgePays completed the sale of its ClearLine point-of-sale engagement platform, managed marketing services business, and a turnkey wireless operation to GPO Plus for $27.5 million in consideration. The transaction, backstopped by a put option with Emerald Shoals Targeted Opportunities Fund, was designed to bolster the balance sheet and pushed stockholders' equity above Nasdaq's listing thresholds.

That divestiture allowed management to sharpen its focus on core prepaid wireless and fintech operations serving roughly 138 million subprime U.S. consumers. The rent-to-own joint venture is positioned as a natural extension of that strategy, giving dealers an additional product to drive foot traffic and recurring engagement. Still, the letter of intent is non-binding, and definitive governance, funding, and operating terms have yet to be finalized.

Micro-Cap Dynamics Amplify the Percentage Move

The magnitude of the move is partly a function of the company's size. With a market capitalization in the single-digit millions and shares trading near the low end of a 52-week range spanning roughly $0.14 to $3.14, SURG remains a thinly traded micro-cap that has declined substantially over the past year. In such stocks, even modest buying interest tied to a positive headline can produce outsized percentage gains, while liquidity and execution risks remain elevated.

Market Context and Trading Activity

The advance was driven by company-specific news rather than a broad sector or index move. SurgePays' rebound stands in contrast to its recent trend, which has been pressured by Nasdaq bid-price deficiency notices and ongoing profitability concerns. The rent-to-own announcement offered investors a tangible growth narrative and a potential new revenue channel within the existing dealer base. The stock's low absolute price means the roughly $0.045 gain translated into a percentage increase well into the double digits, underscoring how price-sensitive and headline-driven the name remains.

What Comes Next for SURG

Investors will now focus on whether the companies execute a definitive operating agreement formalizing the joint venture's governance, funding, and operating terms. Key data points to watch include further dealer onboarding, customer adoption and transaction volumes, and any disclosure of the venture's revenue contribution. Broader risks include the company's history of operating losses, thin analyst coverage, and outstanding Nasdaq compliance matters. Because the letter of intent is non-binding, there is no assure the venture will be completed on the terms described or at all, and the stock's volatility is likely to persist as the story develops.

Trending AI Robots

Tickeron offers hundreds of AI-powered trading bots that scan thousands of tickers to identify patterns and trading opportunities. Only the strongest performers under current market conditions are featured in its curated Trending AI Robots section, where bots vary by strategy, timeframe, performance metrics, and traded symbols. Traders seeking a data-driven approach to navigating fast-moving names like SURG may find it a useful resource. Explore the Trending AI Robots page to see which strategies are currently leading the market.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: SURG

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


SURG's Stochastic Oscillator sits in oversold zone for 2 days

Be on the lookout for a price bounce soon.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The 10-day moving average for SURG crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 77%.

Following a +7.51% 3-day Advance, the price is estimated to grow further. Considering data from situations where SURG advanced for three days, in 203 of 253 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.

Bearish Trend Analysis

The 10-day RSI Indicator for SURG moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 27 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 87%.

The Momentum Indicator moved below the 0 level on November 11, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on SURG as a result. In 79 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 87%.

The Moving Average Convergence Divergence Histogram (MACD) for SURG turned negative on November 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 39 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 87%.

SURG moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SURG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

SURG broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SURG entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 27 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.425) is normal, around the industry mean (2.292). P/E Ratio (-0.111) is within average values for comparable stocks, (-7.252). Projected Growth (PEG Ratio) (0.474) is also within normal values, averaging (8.005). Dividend Yield (0.000) settles around the average of (0.132) among similar stocks. P/S Ratio (0.048) is also within normal values, averaging (5.777).

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. SURG’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SURG’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.

Notable companies

The most notable companies in this group are Verizon Communications (NYSE:VZ), AT&T (NYSE:T), Comcast Corp (NASDAQ:CMCSA), Lumen Technologies (NASDAQ:LUMN).

Industry description

Major telecommunications include companies that make communication possible across the globe – by providing voice and data transmission via multiple channels such as phone or the Internet, through airwaves or cables, through wires or wirelessly. The ease with which we connect with anyone, anywhere in the world is thanks in large part to the infrastructure created by the telecom industry. Some major telecom players include AT&T Inc., Verizon Communications Inc. and Nippon Telegraph and Telephone Corporation.

Market Cap

The average market capitalization across the Major Telecommunications Industry is 17.61B. The market cap for tickers in the group ranges from 714.84K to 225.96B. SFTBY holds the highest valuation in this group at 225.96B. The lowest valued company is CPROF at 714.84K.

High and low price notable news

The average weekly price growth across all stocks in the Major Telecommunications Industry was -4%. For the same Industry, the average monthly price growth was -1%, and the average quarterly price growth was -14%. RDCM experienced the highest price growth at 11%, while FNGR experienced the biggest fall at -43%.

Volume

The average weekly volume growth across all stocks in the Major Telecommunications Industry was 27%. For the same stocks of the Industry, the average monthly volume growth was 9% and the average quarterly volume growth was -7%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 57
Price Growth Rating: 58
SMR Rating: 72
Profit Risk Rating: 82
Seasonality Score: 0 (-100 ... +100)
AI Screener 4
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry MajorTelecommunications

Industry
N/A
Address
3124 Brother Boulevard
Phone
+1 901 302-9587
Employees
262
Web
https://www.surgepays.com
Interact to see
Advertisement
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.